Crinetics Pharmaceuticals, Inc.
CRNXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CRNX. That does not mean none is planned.
Get an email about CRNX's next catalysts
Track Crinetics Pharmaceuticals (CRNX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Randomized: 40 mg Paltusotine | Phase 2 | Carcinoid Syndrome | - | - |
Acromegaly
2 drugs in this indication
Congenital Adrenal Hyperplasia
2 drugs in this indication
SST2-positive Neuroendocrine Neoplasms
1 drug in this indication
Carcinoid Syndrome
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Crinetics Pharmaceuticals, Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in Crinetics Pharmaceuticals, Inc.'s (CRNX) pipeline across Phase 2. Its lead program is Randomized: 40 mg Paltusotine (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Crinetics Pharmaceuticals, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Crinetics Pharmaceuticals, Inc. (CRNX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CRNX biotech catalysts?β
Add CRNX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Crinetics Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
